Financial Snapshot

Revenue
$10.34B
TTM
Gross Margin
86.44%
TTM
Net Earnings
-$489.9M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
252.07%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$14.77B
Q2 2024
Cash
Q2 2024
P/E
-249.8
Sep 18, 2024 EST
Free Cash Flow
-$1.246B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $9.869B $8.931B $7.574B $6.206B $4.163B $3.048B $2.489B $1.702B $1.032B $580.4M $1.212B $1.527B $1.411B $143.4M $101.9M $175.5M $199.0M $216.4M $160.9M $102.7M $69.10M $94.80M $85.30M $153.3M $108.9M $62.60M $49.70M $18.90M $27.50M $23.10M $29.30M $5.800M $4.100M $2.300M
YoY Change 10.51% 17.91% 22.06% 49.08% 36.59% 22.46% 46.2% 64.89% 77.86% -52.11% -20.63% 8.25% 883.91% 40.7% -41.94% -11.81% -8.04% 34.49% 56.67% 48.63% -27.11% 11.14% -44.36% 40.77% 73.96% 25.96% 162.96% -31.27% 19.05% -21.16% 405.17% 41.46% 78.26%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Revenue $9.869B $8.931B $7.574B $6.206B $4.163B $3.048B $2.489B $1.702B $1.032B $580.4M $1.212B $1.527B $1.411B $143.4M $101.9M $175.5M $199.0M $216.4M $160.9M $102.7M $69.10M $94.80M $85.30M $153.3M $108.9M $62.60M $49.70M $18.90M $27.50M $23.10M $29.30M $5.800M $4.100M $2.300M
Cost Of Revenue $1.262B $1.080B $904.2M $736.3M $547.8M $409.5M $275.1M $210.5M $117.2M $39.73M $88.98M $236.7M $63.63M $0.00 $0.00 $42.80M $31.50M $27.10M $9.800M $2.000M
Gross Profit $8.607B $7.850B $6.670B $5.469B $3.615B $2.638B $2.214B $1.492B $915.2M $540.7M $1.123B $1.290B $1.347B $143.4M $101.9M $110.5M $77.40M $35.50M $39.90M $17.00M
Gross Profit Margin 87.21% 87.9% 88.06% 88.14% 86.84% 86.56% 88.95% 87.64% 88.65% 93.16% 92.66% 84.5% 95.49% 100.0% 100.0% 72.08% 71.07% 56.71% 80.28% 89.95%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Selling, General & Admin $1.137B $944.7M $840.1M $770.5M $658.5M $557.6M $496.1M $432.8M $376.6M $305.4M $356.2M $432.7M $400.7M $187.8M $130.2M $101.3M $78.60M $50.30M $44.00M $42.10M $39.10M $41.10M $31.90M $41.40M $40.90M $26.20M $16.20M $25.10M $7.100M $5.500M $3.500M $2.300M $1.100M $900.0K
YoY Change 20.31% 12.45% 9.03% 17.01% 18.09% 12.4% 14.61% 14.94% 23.3% -14.26% -17.68% 7.98% 113.38% 44.24% 28.53% 28.88% 56.26% 14.32% 4.51% 7.67% -4.87% 28.84% -22.95% 1.22% 56.11% 61.73% -35.46% 253.52% 29.09% 57.14% 52.17% 109.09% 22.22%
% of Gross Profit 13.21% 12.03% 12.59% 14.09% 18.22% 21.14% 22.41% 29.02% 41.15% 56.49% 31.72% 33.53% 29.75% 130.99% 127.77% 37.47% 52.84% 73.8% 40.6% 147.65%
Research & Development $3.690B $2.540B $3.051B $1.830B $1.755B $1.416B $1.325B $1.048B $995.9M $855.5M $882.1M $765.9M $707.7M $637.4M $550.3M $516.9M $519.2M $379.2M $248.5M $192.2M $199.6M $198.3M $142.0M $102.4M $85.00M $76.90M $57.80M $40.30M $41.50M $34.80M $23.20M $11.50M $7.700M $5.500M
YoY Change 45.26% -16.74% 66.77% 4.27% 23.86% 6.93% 26.43% 5.2% 16.41% -3.01% 15.17% 8.22% 11.03% 15.83% 6.46% -0.44% 36.92% 52.6% 29.29% -3.71% 0.66% 39.65% 38.67% 20.47% 10.53% 33.04% 43.42% -2.89% 19.25% 50.0% 101.74% 49.35% 40.0%
% of Gross Profit 42.87% 32.36% 45.74% 33.45% 48.53% 53.69% 59.84% 70.23% 108.82% 158.22% 78.55% 59.36% 52.54% 444.6% 540.04% 92.67% 109.82% 216.62% 144.86% 237.06%
Depreciation & Amortization $181.3M $148.3M $125.6M $109.5M $106.9M $72.42M $61.40M $61.40M $62.34M $63.26M $48.37M $38.19M $35.04M $30.46M $30.10M $32.20M $27.50M $25.90M $27.30M $29.60M $23.40M $24.90M $17.80M $12.80M $9.700M $6.900M $4.600M $3.300M $3.700M $3.500M $3.900M $2.800M $1.800M $1.400M
YoY Change 22.25% 18.07% 14.7% 2.43% 47.61% 17.95% 0.0% -1.52% -1.44% 30.79% 26.64% 8.99% 15.04% 1.19% -6.52% 17.09% 6.18% -5.13% -7.77% 26.5% -6.02% 39.89% 39.06% 31.96% 40.58% 50.0% 39.39% -10.81% 5.71% -10.26% 39.29% 55.56% 28.57%
% of Gross Profit 2.11% 1.89% 1.88% 2.0% 2.96% 2.75% 2.77% 4.12% 6.81% 11.7% 4.31% 2.96% 2.6% 21.25% 29.54% 11.58% 12.53% 19.44% 11.53% 19.41%
Operating Expenses $4.775B $3.485B $3.891B $2.600B $2.413B $1.974B $1.821B $1.481B $1.372B $1.161B $1.238B $1.199B $1.108B $825.2M $694.7M $633.9M $611.7M $441.7M $302.7M $239.9M $241.9M $242.7M $177.5M $147.9M $129.0M $103.1M $74.00M $65.30M $48.60M $40.30M $26.70M $13.80M $8.800M $6.400M
YoY Change 37.02% -10.44% 49.66% 7.75% 22.23% 8.42% 22.98% 7.87% 18.23% -6.25% 3.31% 8.13% 34.32% 18.79% 9.59% 3.63% 38.49% 45.92% 26.18% -0.83% -0.33% 36.73% 20.01% 14.65% 25.12% 39.32% 13.32% 34.36% 20.6% 50.94% 93.48% 56.82% 37.5%
Operating Profit $3.832B $4.307B $2.782B $2.856B $1.198B $635.2M $123.2M $9.936M -$466.9M -$692.4M -$610.0M $46.73M $113.8M -$696.1M -$592.8M -$37.40M -$51.60M -$67.60M -$34.10M -$48.30M
YoY Change -11.04% 54.83% -2.6% 138.52% 88.54% 415.36% 1140.37% -102.13% -32.57% 13.51% -1405.47% -58.95% -116.35% 17.42% -27.52% -23.67% 98.24% -29.4%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Interest Expense $570.6M -$59.30M -$39.50M $58.15M $58.50M $72.47M $69.30M -$81.43M -$84.21M -$72.86M -$22.93M $16.65M $38.45M $19.28M -$10.00M $2.900M $28.50M $26.30M -$53.50M -$8.000M -$1.900M $11.00M $25.80M $21.70M $11.30M $16.40M $14.80M $5.400M -$500.0K -$400.0K -$500.0K -$500.0K -$400.0K -$300.0K
YoY Change -1062.23% 50.13% -167.93% -0.6% -19.28% 4.58% -185.1% -3.29% 15.57% 217.82% -237.67% -56.69% 99.49% -292.75% -444.83% -89.82% 8.37% -149.16% 568.75% 321.05% -117.27% -57.36% 18.89% 92.04% -31.1% 10.81% 174.07% -1180.0% 25.0% -20.0% 0.0% 25.0% 33.33%
% of Operating Profit 14.89% -1.38% -1.42% 2.04% 4.89% 11.41% 56.23% -819.57% 35.64% 33.78%
Other Income/Expense, Net -$22.80M -$164.8M $4.900M $296.6M $192.2M -$790.0K -$81.38M $4.130M -$6.715M $30.40M $6.890M $309.0K -$15.69M $0.00 -$18.10M $0.00 $0.00 -$5.200M $0.00 -$3.400M $0.00 $0.00 -$1.300M -$15.80M -$800.0K
YoY Change -86.17% -3463.27% -98.35% 54.32% -24429.11% -99.03% -2070.51% -161.5% -122.09% 341.22% 2129.77% -101.97% -100.0% -100.0% -100.0% -100.0% -91.77% 1875.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Pretax Income $4.380B $4.232B $2.730B $3.117B $1.395B $812.1M $330.3M -$147.9M -$272.3M -$645.5M -$10.64M $231.5M $343.5M -$719.9M -$642.2M -$459.9M -$391.3M -$207.9M -$203.4M -$166.2M -$266.4M -$137.0M -$80.20M -$31.60M -$41.20M -$51.20M -$19.30M -$43.10M -$21.50M -$17.60M $2.100M -$8.500M -$5.100M -$4.300M
YoY Change 3.48% 55.01% -12.4% 123.45% 71.77% 145.83% -323.41% -45.7% -57.81% 5967.54% -104.59% -32.6% -147.72% 12.09% 39.64% 17.53% 88.22% 2.21% 22.38% -37.61% 94.45% 70.82% 153.8% -23.3% -19.53% 165.28% -55.22% 100.47% 22.16% -938.1% -124.71% 66.67% 18.6%
Income Tax $760.2M $910.4M $388.3M $405.2M $218.1M -$1.487B -$107.3M $16.67M $30.38M $6.958M -$122.4M -$275.0K $19.27M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$200.0K $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00
% Of Pretax Income 17.36% 21.51% 14.22% 13.0% 15.64% -183.09% -32.49% -0.12% 5.61% 4.76%
Net Earnings $3.620B $3.322B $2.342B $2.712B $1.177B $2.097B $263.5M -$112.1M -$556.3M -$738.6M -$445.0M -$107.0M $29.57M -$754.6M -$642.2M -$459.9M -$391.3M -$206.9M -$203.4M -$166.2M -$196.8M -$108.6M -$66.20M -$34.70M -$41.20M -$51.00M -$19.30M -$43.10M -$21.50M -$17.60M $2.000M -$8.500M -$5.100M -$4.300M
YoY Change 8.96% 41.84% -13.63% 130.43% -43.88% 695.83% -335.14% -79.86% -24.67% 65.96% 315.79% -461.91% -103.92% 17.51% 39.64% 17.53% 89.13% 1.72% 22.38% -15.55% 81.22% 64.05% 90.78% -15.78% -19.22% 164.25% -55.22% 100.47% 22.16% -980.0% -123.53% 66.67% 18.6%
Net Earnings / Revenue 36.68% 37.2% 30.92% 43.7% 28.27% 68.8% 10.59% -6.58% -53.89% -127.25% -36.72% -7.01% 2.1% -526.35% -630.23% -262.05% -196.63% -95.61% -126.41% -161.83% -284.8% -114.56% -77.61% -22.64% -37.83% -81.47% -38.83% -228.04% -78.18% -76.19% 6.83% -146.55% -124.39% -186.96%
Basic Earnings Per Share $14.05 $12.97 $9.09 $10.44 $4.58 $8.24 $1.06 -$0.46 -$2.31 -$3.14 -$1.98 -$0.50 $0.14 -$3.77
Diluted Earnings Per Share $13.89 $12.82 $9.01 $10.29 $4.51 $8.09 $1.04 -$0.46 -$2.31 -$3.14 -$1.98 -$0.50 $0.14 -$3.77 -$3.706M -$3.271M -$3.033M -$1.828M -$2.280M -$2.115M -$2.556M -$1.435M -$888.6K -$512.6K -$658.1K -$826.6K -$349.6K -$1.099M -$623.2K -$557.0K $80.32K -$351.2K -$314.8K -$323.3K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990
Cash & Short-Term Investments $11.22B $10.78B $7.525B $6.659B $3.808B $3.168B $2.089B $1.435B $1.042B $1.387B $1.465B $1.321B $969.0M $1.031B $1.285B $832.0M $461.0M $705.0M $361.0M $386.0M $583.0M $635.0M $743.0M $814.0M $152.0M $274.0M $329.0M $144.0M $87.00M $106.0M $52.00M $44.00M $51.00M $4.000M
YoY Change 4.08% 43.24% 13.0% 74.87% 20.2% 51.65% 45.57% 37.72% -24.87% -5.32% 10.9% 36.33% -6.01% -19.77% 54.45% 80.48% -34.61% 95.29% -6.48% -33.79% -8.19% -14.54% -8.72% 435.53% -44.53% -16.72% 128.47% 65.52% -17.92% 103.85% 18.18% -13.73% 1175.0%
Cash & Equivalents $11.22B $10.50B $6.795B $5.988B $3.109B $2.650B $1.665B $1.184B $715.0M $625.0M $569.0M $489.0M $475.0M $243.0M $447.0M $389.0M $356.0M $213.0M $78.00M $55.00M $98.00M $108.0M $189.0M $347.0M $48.00M $34.00M $95.00M $39.00M $28.00M $72.00M $29.00M $12.00M $28.00M $4.000M
Short-Term Investments $849.2M $274.5M $729.9M $671.0M $699.0M $518.0M $423.0M $251.0M $328.0M $762.0M $896.0M $832.0M $494.0M $788.0M $838.0M $443.0M $105.0M $491.0M $283.0M $331.0M $485.0M $527.0M $554.0M $467.0M $105.0M $240.0M $234.0M $105.0M $59.00M $35.00M $24.00M $32.00M $24.00M $0.00
Other Short-Term Assets $623.7M $553.5M $545.8M $308.0M $214.0M $136.0M $138.0M $115.0M $130.0M $52.00M $24.00M $95.00M $67.00M $13.00M $13.00M $12.00M $5.000M $4.000M $3.000M $3.000M $3.000M $8.000M $13.00M $9.000M $5.000M $3.000M $3.000M $2.000M $1.000M $0.00 $1.000M $0.00 $0.00 $0.00
YoY Change 12.68% 1.41% 77.21% 43.93% 57.35% -1.45% 20.0% -11.54% 150.0% 116.67% -74.74% 41.79% 415.38% 0.0% 8.33% 140.0% 25.0% 33.33% 0.0% 0.0% -62.5% -38.46% 44.44% 80.0% 66.67% 0.0% 50.0% 100.0% -100.0%
Inventory $738.8M $460.6M $353.1M $281.0M $168.0M $124.0M $112.0M $78.00M $57.00M $31.00M $14.00M $30.00M $112.0M $0.00
Prepaid Expenses
Receivables $1.563B $1.442B $1.137B $885.0M $634.0M $410.0M $281.0M $201.0M $178.0M $76.00M $86.00M $143.0M $183.0M $13.00M $10.00M $23.00M $31.00M $63.00M $21.00M $12.00M $7.000M $13.00M $20.00M $34.00M $11.00M $5.000M $3.000M $1.000M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $5.000M $29.00M $3.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $14.14B $13.23B $9.561B $8.133B $4.823B $3.843B $2.649B $1.832B $1.407B $1.547B $1.589B $1.590B $1.331B $1.057B $1.307B $868.0M $497.0M $771.0M $385.0M $401.0M $594.0M $657.0M $776.0M $857.0M $168.0M $282.0M $335.0M $147.0M $88.00M $107.0M $53.00M $44.00M $52.00M $5.000M
YoY Change 6.87% 38.43% 17.55% 68.63% 25.5% 45.07% 44.6% 30.21% -9.05% -2.64% -0.06% 19.46% 25.92% -19.13% 50.58% 74.65% -35.54% 100.26% -3.99% -32.49% -9.59% -15.34% -9.45% 410.12% -40.43% -15.82% 127.89% 67.05% -17.76% 101.89% 20.45% -15.38% 940.0%
Property, Plant & Equipment $1.453B $1.456B $1.424B $1.284B $833.0M $812.0M $789.0M $698.0M $698.0M $716.0M $697.0M $434.0M $133.0M $72.00M $62.00M $68.00M $67.00M $62.00M $55.00M $64.00M $80.00M $96.00M $80.00M $44.00M $36.00M $25.00M $18.00M $11.00M $8.000M $8.000M $8.000M $7.000M $5.000M $4.000M
YoY Change -0.2% 2.2% 10.93% 54.14% 2.59% 2.92% 13.04% 0.0% -2.51% 2.73% 60.6% 226.32% 84.72% 16.13% -8.82% 1.49% 8.06% 12.73% -14.06% -20.0% -16.67% 20.0% 81.82% 22.22% 44.0% 38.89% 63.64% 37.5% 0.0% 0.0% 14.29% 40.0% 25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.498B $98.60M $85.80M $21.00M $20.00M $20.00M $0.00 $7.000M $57.00M $65.00M $25.00M $19.00M $26.00M $26.00M $7.000M $74.00M $0.00 $0.00 $0.00
YoY Change 2433.27% 14.92% 308.57% 0.0% -100.0% -87.72% -12.31% 160.0% 31.58% -26.92% 0.0% 271.43% -90.54%
Other Assets $2.707B $1.670B $959.5M $911.0M $1.260B $1.540B $8.000M $12.00M $29.00M $3.000M $3.000M $42.00M $45.00M $51.00M $41.00M $45.00M $31.00M $32.00M $44.00M $56.00M $32.00M $37.00M $42.00M $32.00M $17.00M $10.00M $6.000M $4.000M $3.000M $1.000M $0.00 $0.00 $0.00 $0.00
YoY Change 62.11% 74.06% 5.32% -27.7% -18.18% 19150.0% -33.33% -58.62% 866.67% 0.0% -92.86% -6.67% -11.76% 24.39% -8.89% 45.16% -3.13% -27.27% -21.43% 75.0% -13.51% -11.9% 31.25% 88.24% 70.0% 66.67% 50.0% 33.33% 200.0%
Total Long-Term Assets $8.586B $4.916B $3.872B $3.619B $3.495B $2.403B $897.0M $1.065B $1.092B $788.0M $730.0M $1.169B $873.0M $668.0M $648.0M $112.0M $104.0M $151.0M $164.0M $144.0M $130.0M $159.0M $149.0M $84.00M $128.0M $35.00M $24.00M $14.00M $11.00M $9.000M $8.000M $7.000M $5.000M $4.000M
YoY Change 74.65% 26.97% 6.99% 3.55% 45.44% 167.89% -15.77% -2.47% 38.58% 7.95% -37.55% 33.91% 30.69% 3.09% 478.57% 7.69% -31.13% -7.93% 13.89% 10.77% -18.24% 6.71% 77.38% -34.38% 265.71% 45.83% 71.43% 27.27% 22.22% 12.5% 14.29% 40.0% 25.0%
Total Assets $22.73B $18.15B $13.43B $11.75B $8.318B $6.246B $3.546B $2.897B $2.499B $2.335B $2.319B $2.759B $2.204B $1.725B $1.955B $980.0M $601.0M $922.0M $549.0M $545.0M $724.0M $816.0M $925.0M $941.0M $296.0M $317.0M $359.0M $161.0M $99.00M $116.0M $61.00M $51.00M $57.00M $9.000M
YoY Change
Accounts Payable $3.020B $303.9M $195.0M $155.0M $88.00M $111.0M $74.00M $61.00M $75.00M $71.00M $49.00M $101.0M $75.00M $36.00M $37.00M $52.00M $33.00M $15.00M $6.000M $7.000M $12.00M $17.00M $12.00M $8.000M $7.000M $6.000M $5.000M $2.000M $3.000M $1.000M $3.000M $1.000M $1.000M $0.00
YoY Change 893.81% 55.85% 25.81% 76.14% -20.72% 50.0% 21.31% -18.67% 5.63% 44.9% -51.49% 34.67% 108.33% -2.7% -28.85% 57.58% 120.0% 150.0% -14.29% -41.67% -29.41% 41.67% 50.0% 14.29% 16.67% 20.0% 150.0% -33.33% 200.0% -66.67% 200.0% 0.0%
Accrued Expenses $2.589B $2.052B $1.501B $1.311B $1.056B $604.0M $446.0M $314.0M $314.0M $243.0M $274.0M $267.0M $257.0M $143.0M $126.0M $106.0M $104.0M $98.00M $60.00M $95.00M $100.0M $34.00M $36.00M $28.00M $13.00M $8.000M $7.000M $3.000M $4.000M $2.000M $1.000M $1.000M $1.000M $0.00
YoY Change 26.16% 36.75% 14.46% 24.15% 74.83% 35.43% 42.04% 0.0% 29.22% -11.31% 2.62% 3.89% 79.72% 13.49% 18.87% 1.92% 6.12% 63.33% -36.84% -5.0% 194.12% -5.56% 28.57% 115.38% 62.5% 14.29% 133.33% -25.0% 100.0% 100.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $300.0M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $50.60M $40.80M $46.90M $42.00M $30.00M $10.00M $23.00M $19.00M $87.00M $32.00M $17.00M $14.00M $0.00 $143.0M $47.00M $21.00M $37.00M $104.0M $3.000M $5.000M $19.00M $2.000M $5.000M $5.000M $5.000M $5.000M $4.000M $3.000M $2.000M $2.000M $2.000M $2.000M $1.000M $1.000M
YoY Change 24.02% -13.01% 11.67% 40.0% 200.0% -56.52% 21.05% -78.16% 171.88% 88.24% 21.43% -100.0% 204.26% 123.81% -43.24% -64.42% 3366.67% -40.0% -73.68% 850.0% -60.0% 0.0% 0.0% 0.0% 25.0% 33.33% 50.0% 0.0% 0.0% 0.0% 100.0% 0.0%
Total Short-Term Liabilities $3.547B $2.742B $2.142B $1.878B $1.335B $1.120B $807.0M $793.0M $506.0M $368.0M $398.0M $433.0M $392.0M $475.0M $285.0M $217.0M $199.0M $251.0M $100.0M $154.0M $139.0M $65.00M $92.00M $70.00M $38.00M $22.00M $19.00M $8.000M $9.000M $6.000M $7.000M $4.000M $3.000M $2.000M
YoY Change 29.37% 28.02% 14.06% 40.67% 19.2% 38.79% 1.77% 56.72% 37.5% -7.54% -8.08% 10.46% -17.47% 66.67% 31.34% 9.05% -20.72% 151.0% -35.06% 10.79% 113.85% -29.35% 31.43% 84.21% 72.73% 15.79% 137.5% -11.11% 50.0% -14.29% 75.0% 33.33% 50.0%
Long-Term Debt $376.1M $430.8M $509.8M $539.0M $539.0M $582.0M $584.0M $521.0M $739.0M $793.0M $490.0M $683.0M $400.0M $400.0M $122.0M $288.0M $0.00 $20.00M $180.0M $338.0M $341.0M $326.0M $323.0M $357.0M $9.000M $12.00M $9.000M $7.000M $5.000M $5.000M $4.000M $3.000M $2.000M $2.000M
YoY Change -12.7% -15.5% -5.42% 0.0% -7.39% -0.34% 12.09% -29.5% -6.81% 61.84% -28.26% 70.75% 0.0% 227.87% -57.64% -100.0% -88.89% -46.75% -0.88% 4.6% 0.93% -9.52% 3866.67% -25.0% 33.33% 28.57% 40.0% 0.0% 25.0% 33.33% 50.0% 0.0%
Other Long-Term Liabilities $1.226B $1.065B $680.7M $648.0M $360.0M $109.0M $106.0M $111.0M $49.00M $62.00M $75.00M $129.0M $203.0M $186.0M $292.0M $238.0M $131.0M $145.0M $29.00M $18.00M $52.00M $47.00M $35.00M $0.00 $0.00
YoY Change 15.11% 56.5% 5.05% 80.0% 230.28% 2.83% -4.5% 126.53% -20.97% -17.33% -41.86% -36.45% 9.14% -36.3% 22.69% 81.68% -9.66% 400.0% 61.11% -65.38% 10.64% 34.29%
Total Long-Term Liabilities $1.602B $1.496B $1.191B $1.187B $899.0M $691.0M $690.0M $632.0M $788.0M $855.0M $565.0M $812.0M $603.0M $586.0M $414.0M $526.0M $131.0M $165.0M $209.0M $356.0M $393.0M $373.0M $358.0M $357.0M $9.000M $12.00M $9.000M $7.000M $5.000M $5.000M $4.000M $3.000M $2.000M $2.000M
YoY Change 7.11% 25.67% 0.29% 32.04% 30.1% 0.14% 9.18% -19.8% -7.84% 51.33% -30.42% 34.66% 2.9% 41.55% -21.29% 301.53% -20.61% -21.05% -41.29% -9.41% 5.36% 4.19% 0.28% 3866.67% -25.0% 33.33% 28.57% 40.0% 0.0% 25.0% 33.33% 50.0% 0.0%
Total Liabilities $5.150B $4.238B $3.333B $3.065B $2.233B $1.811B $1.517B $1.740B $1.559B $1.260B $963.0M $1.760B $1.417B $1.221B $859.0M $742.0M $330.0M $416.0M $310.0M $510.0M $532.0M $437.0M $450.0M $427.0M $47.00M $34.00M $28.00M $15.00M $14.00M $11.00M $11.00M $7.000M $5.000M $4.000M
YoY Change 21.51% 27.18% 8.73% 37.26% 23.3% 19.38% -12.82% 11.61% 23.73% 30.84% -45.28% 24.21% 16.05% 42.14% 15.77% 124.85% -20.67% 34.19% -39.22% -4.14% 21.74% -2.89% 5.39% 808.51% 38.24% 21.43% 86.67% 7.14% 27.27% 0.0% 57.14% 40.0% 25.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $122.38 Billion

About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The company is headquartered in Boston, Massachusetts and currently employs 5,400 full-time employees. The firm is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. The company has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Its marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). The company is developing non-autologous (allogeneic) fully differentiated, stem-cell derived islet cell therapies designed to replace insulin-producing islet cells that are destroyed in people with T1D.

Industry: Pharmaceutical Preparations Peers: AbbVie Inc Alnylam Pharmaceuticals Inc Amgen Inc Biogen Inc Gilead Sciences Inc Moderna Inc Regeneron Pharmaceuticals Inc Seagen Inc.